This compound is a sulfonylated nitro-triazole reagent used as a pharmaceutical intermediate in oligonucleotide synthesis. Its structure features a triazole ring with a nitro group and a mesitylenesulfonyl substituent, contributing to its role in nucleoside activation chemistry.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 74257-00-4
5'-DMT-PseudoUridine
pharmaceutical intermediate
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methyluridine
pharmaceutical intermediate
(S)-GNA-A(Bz)-phosphoramidite
pharmaceutical intermediate
(S)-GNA-C(Bz)-phosphoramidite
pharmaceutical intermediate
Adc-13
pharmaceutical intermediate
3-Bromo-5-methylpyrazin-2-amine
pharmaceutical intermediate
(2H3)Methylammonium chloride
pharmaceutical intermediate
3-Bromo-7-azaindole
pharmaceutical intermediate
3-nitro-1-(2,4,6-trimethylphenyl)sulfonyl-1,2,4-triazole
SFYDWLYPIXHPML-UHFFFAOYSA-N
CC1=CC(=C(C(=C1)C)S(=O)(=O)N2C=NC(=N2)[N+](=O)[O-])C